Efficacy (and safety) of vaccination against SARS-CoV-2 in cancer patients on active treatment
Since the COVID-19 pandemic, cancer patients have been recognized as a group with an increased risk of complications, if they become infected with the SARS-CoV-2 virus. However, they were not included in registrational trials for COVID-19 vaccines. In the last few months data from studies investiga...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | SL |
| Published: |
Institute of Oncology Ljubljana
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/88e12c42dff240bfa773b79412dac2c8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|